Regulation News: Breaking Regulation News, Comments and Articles. - Page: 3

01:49 EDT 30th March 2015 | BioPortfolio

Regulation News - Page: 3RSS

Read the latest Regulation News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Regulation.

Search or Follow Our Regulation - Page: 3 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Regulation - Page: 3 News.

Showing "regulation regulatory" News Articles 51 to 75 of 6,400+

Thursday 26th March 2015

Board of Directors of STALLERGENES: Update on the Project to Combine STALLERGENES and GREER Laboratories

Regulatory News: STALLERGENES S.A. (Paris:GENP) (EURONEXT Paris) announced that it had received a proposal from its majority shareholder, Ares Life Sciences, which sought to bring together the act...

Invitae Presents New Data Demonstrating Use of Next-Generation Sequencing for Multi-Gene Panels at the 2015 American College of Medical Genetics Annual Clinical Genetics Meeting

-- Company also expands test catalog; now offers full coverage of CHEK2 gene and four new cancer-related genes -- Invitae Corporation (NYSE:NVTA), a genetic information company, is presenting seven posters at the 2015 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting, including data demonstrating the use of next-generation se...

Harmony Healthcare International Releases 2015 Post Acute Care Trends Report

Over 1,200 Survey Respondents Detail Biggest Challenges for Industry Topsfield, MA (PRWEB) March 26, 2015 Documentation topped the list of biggest challenges faced by Skilled Nursing and Assisted Living facilities during 2014, despite the introduction of many regulatory and policy changes during the year. The survey queried Administrators, Directors of Nursing, Charge Nurses, Rehabilitation Ther...

Twinlab Consolidation Corporation Announces Industry Veteran Mark Walsh as the Company's New Chief Operating Officer

NEW YORK, March 26, 2015 /PRNewswire/ -- Twinlab Consolidation Corporation (TCC), an employee-controlled industry-focused health and wellness company committed to developing top brands, is pleased to announce the addition of Mark Walsh as Executive Vice President and Chief Operating Officer. "TCC continues to strengthen its position in the industry and maintain a commitment to being an indu...

BIO Applauds SEC for Publishing Final Guidance on Regulation A+

Reg A+ enables emerging biotech companies to raise capital while reducing regulatory compliance The Biotechnology Industry Organization (BIO) applauds the Securities and Exchange Commission (SEC) for finalizing a provision of the Jumpstart Our Business Startups (JOBS) Act that will further encourage biotech capital formation and investment by raising t...

Clinical Data on Exactech Technologies for Shoulder, Knee and Ankle Replacement Surgery Presented at the 2015 Orthopaedic Research Society Annual Meeting

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, extremities, spine and biologic materials, presented scientific posters and presentations regarding its latest advancements for shoulder, knee and ankle replacement surgery during the 2015 Orthopaedic Research Society (ORS) annual meeting in Las

SQI Diagnostics Inc. Announces Adjournment of Meeting

TORONTO, March 26, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF) announced that after dealing with certain matters, including the appointment of auditors, its annual and special meeting of shareholders held on March 26, 2015 (the "Meeting") was adjourned, as previously disclosed on March 25, 2015, until April 8, 2015 at 11:00 a.m. (Toronto time). The ...

Elekta Issues a SEK 1 Billion Bond with Five Year Maturity

Regulatory News: Elekta (EKTA-B.ST) (STO:EKTAB) has today issued a SEK 1 billion bond, with five year maturity, under its existing Medium Term Note Program with a total limit of SEK 5 billion. The bond is divided in two tranches (the “Bonds”), fixed and floating. The first tranche of SEK 300 million has a fixed coupon rate of 1.580 ...

Merck Announces Collaboration with the American Diabetes Association to Educate Adults with Diabetes About Increased Risk for Serious Diseases like Pneumococcal Pneumonia

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced a collaboration with the American Diabetes Association (ADA). The collaboration aims to educate adults with diabetes about their increased risk for potentially serious health problems, including pneumococcal pneumonia, influenza (flu) and hepatitis B, making it importan...

City of Baytown Health Department Completes Implementation Project for Leading Environmental Health Software

CITY OF BAYTOWN, Texas, March 26, 2015 /PRNewswire/ -- Decade Software Company, LLC, premier provider of enterprise web-based and mobile software applications for regulatory agencies, announced today that the City of Baytown Health Department is now live with Decade's EnvisionConnect product suite. The City of Baytown exclusively uses EnvisionConnect to manage its Food Service, Public Pools, ...

UPDATE - Epistem focused on Genedrive India approval in second half

---adds share price and broker comment--- Biotech Epistem (LON:EHP) will focus in the second half in obtaining Indian regulatory approval for its flagship Genedrive TB diagnostic device, it said, reporting a widened operating loss in its first half. ...

What does successful regulation look like?

Good regulation starts with a genuine need. Steele and colleagues (doi:10.1136/bmj.h1485) identify just such a need in describing the unregulated online market in human breast milk. Surveys reveal a...

pSivida Corp. Completes Targeted Enrollment of Phase III Trial of Medidur™ for Posterior Uveitis

pSivida Corp. (NASDAQ:PSDV; ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced the completion of the originally targeted enrollment of 120 patients in its pivotal Phase III clinical trial of Medidur™ for the treatment of posterior uveitis, a blinding eye disease. pSivida will permi...

Regulatory Considerations for Using Social and Digital Media in Clinical Trial Patient Recruitment

Clinical Informatics News | Contributed Commentary | Social and digital media can be powerful tools for recruiting clinical trial participants and speeding up enrollment, but there are several regulatory as well as operational considerations to keep ...

BRIEF-Tasly Pharma's controlling shareholder gets regulatory approval to issue exchangeable bonds

* Says controlling shareholder gets securities regulator's approval to issue exchangeable bonds

PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services

BOSTON, March 26, 2015 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced today that the Company has signed a definitive agreement to acquire all of the business assets of privately-owned Quantum Solutions India ("QSI"), a leading provider of specialized pharmacovigilance services, based in Chandigarh, India.  Pharmacovigi...

Kineta’s Novel Antiviral Compounds Inhibit Broad Array of Emerging and Current Viruses Including Ebola

Kineta takes unique approach to Ebola by targeting host response as potential therapy Small molecule compounds also effective against Dengue, Flu, West Nile, RSV, Lassa Fever and coronaviruses by activating immune system Kineta, Inc., a biotechnology company focused on the development of immune modulating drugs for critical diseases, today pre...

MJ Freeway, Industry-Leading Software Solution for Cannabis Businesses, Featured in CNBC Special "How I Did It"

DENVER, March 26, 2015 /PRNewswire/ -- CNBC profiled MJ Freeway, a business software company for the cannabis industry, in part of a series "How I Did It," which features companies with unique paths to success. "MJ Freeway Takes the High Road" released yesterday, illustrates how two tech entrepreneurs from Telluride, Colorado became the leading IT providers to the marijuana industry. Writer ...

Shire and Cincinnati Children's Establish Rare Disease Research Collaboration

LEXINGTON, Massachusetts and CINCINNATI, March 26, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) and Cincinnati Children's Hospital Medical Center today announced a three-year, broad research collaboration for rare diseases. The goal of the collaboration is to discover and develop novel therapies to treat rare diseases with high unmet medical need combining Shire's development and ...

IGI Laboratories, Inc. Announces First ANDA Submission Of 2015

BUENA, N.J., March 26, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted its first abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA) of 2015, which brings the Company's total number of ANDA submissions now pending at the FDA to twenty-three. Jason Grenfell-...

Moberg Pharma Announces Grant of EU Patent for MOB-015 Related to Topical Treatment of Onychomycosis (Nail Fungus)

Regulatory News: Moberg Pharma AB (STO:MOB) today announced that the European Patent Office has issued Patent no. 2 672 962, relating to its topical treatment MOB-015 for onychomycosis (nail fungu...

Epistem focused on Genedrive India approval in second half

Biotech Epistem (LON:EHP) will focus in the second half in obtaining Indian regulatory approval for its flagship Genedrive TB diagnostic device, it said, as it reported a widened operating loss in its first half. The launch in India will mark the beg...

Alcohol advertising has little effect on overall consumption, study finds

Despite alcohol advertising facing increasing regulatory pressure in the U.S. and abroad, new research from The University of Texas at Austin shows that advertising has little if any effect on overall alcohol consumption.

Pre-Earnings Calithera Biosciences Inc. Analyst Report Issued by BrokerBank Securities, Inc.

NEW YORK, March 26, 2015 /PRNewswire/ -- Calithera Biosciences Inc. (NASDAQ: CALA) based in San Francisco, CA a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer will be reporting fourth quarter and year-end earnings this morning. Anticipation of this rele...

T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks